Mental Health TALK SAFE Act of 2026
H.R. 6994119th Congress

Mental Health TALK SAFE Act of 2026

Introduced in the HouseRep. Neal Dunn (R-FL-2)116 sections · 10 min read
Version: ih · Apr 20, 2026

Section 1. Short title

This Act may be cited as the Mental Health TALK SAFE Act of 2026.

(a) Definition of valid prescription

Section 309(e)(2)(A) of the Controlled Substances Act (21 U.S.C. 829(e)(2)(A)) is amended—

(1) in clause (i), by striking or at the end;

(2) in clause (ii), by striking the period at the end and inserting a semicolon; and

(3) by adding at the end the following:

(iii) a telehealth practitioner who, for purposes of prescribing an approved mental health controlled substance, has conducted at least 1 telehealth evaluation of the patient; or

(iv) a practitioner who, for purposes of prescribing a controlled substance in schedule II, III, IV, or V for the treatment of an opioid use disorder, has conducted at least 1 telehealth evaluation of the patient.

(b) Definition of covering practitioner

Section 309(e)(2)(C)(i) of such Act (21 U.S.C. 829(e)(2)(C) (i)) is amended to read as follows:

(i) has conducted at least 1 in-person medical evaluation of the patient, an evaluation of the patient through the practice of telemedicine, or a telehealth evaluation of the patient, within the previous 90 days; and

(c) Additional definitions

Section 309(e)(2) of such Act (21 U.S.C. 829(e)(2)) is amended by adding at the end the following:

(D) The term approved mental health controlled substance means a controlled substance in schedule II non-narcotics, III, IV, or V that is being prescribed—

(i) for the treatment of a mental health disorder; and

(ii) only for the conditions, and only in the manner of administration and oversight, approved by the Food and Drug Administration.

(E) The term exempt entity means—

(i) a federally qualified health center;

(ii) a hospital;

(iii) a non-profit organization;

(iv) a Federal, State, or local government agency; or

(v) an exempt health care organization.

(F) The term exempt health care organization means a legal entity that, directly or indirectly, acquires all, or substantially all, of the stock, equity interests, or assets of, or merges with or into, a telehealth entity where such telehealth entity, as of the effective date of such acquisition or merger—

(i) has met the criteria to be a telehealth entity for each of the previous 24 months;

(ii) employs at least 250 psychiatrists who each work at least 30 hours per week for the telehealth entity; and

(iii) has at least 75 percent of the telehealth entity’s total patient volume attributed to individuals who are direct patients of the telehealth entity.

(G) The term federally qualified health center means an organization described in section 1861(aa)(4) of the Social Security Act (42 U.S.C. 1395x(aa)(4)).

(H) The term health care provider means any individual who—

(i) is engaged in the delivery of health care services in a State; and

(ii) is required by State law (including regulations) to be licensed or certified by the State to engage in the delivery of such services in the State.

(I) The term hospital means an institution in any State in which State or applicable local law provides for the licensing of hospitals, that is—

(i) licensed as a hospital pursuant to such law; or

(ii) approved, by the agency of such State or locality responsible for licensing hospitals, as meeting the standards established for such licensing.

(J) The term interactive telecommunications system means the multimedia communications equipment that includes, at a minimum, audio-only or audio-video equipment permitting two-way, real-time interactive communication between the patient and the health care provider.

(K) The term nonprofit organization means an organization described in section 501(c)(3) of the Internal Revenue Code of 1986 that is exempt from taxation under section 501(a) of such Act.

(L) The term physician means a doctor of medicine or osteopathy legally authorized to practice medicine by the State in which such individual performs such function or action.

(i) The term psychiatric-mental health advanced practice nurse means a registered professional nurse who meets the requirements specified in clause (ii) or (iii).

(ii) If the State specifies qualifications for psychiatric-mental health advanced practices nurses, the individual must—

(I) be currently licensed to practice in the State as a registered professional nurse; and

(II) meet the State requirements for qualification as a psychiatric-mental health advanced practice nurse in the State in which the individual furnishes the services.

(iii) If the State does not specify qualifications for psychiatric-mental health advance practice nurses, the individual must—

(I) meet the qualifications for nurses in advanced practice or general nurse practitioners as defined by the State; and

(II) maintain an active psychiatric-mental health nursing certification from the American Nurses Credentialing Center or the American Academy of Nurse Practitioners Certification Board.

(N) The term psychiatrist means a physician who has completed a psychiatry residency program accredited by the Accreditation Council for Graduate Medical Education and whose practice focuses predominantly on the diagnosis, treatment, prevention, or study of mental health disorders.

(i) The term telehealth affiliate means as to any telehealth entity, any other legal entity that—

(I) directly or indirectly, is in control of, is controlled by, or is under common control with, such telehealth entity; or

(II) provides the majority of the administrative or business services that do not constitute the practice of medicine or any other licensed profession, to, or on behalf of, such telehealth entity.

(ii) For purposes of this definition, control of an entity means the power, directly or indirectly, to direct or cause the direction of the management and policies of such entity whether by contract or otherwise.

(P) The term telehealth entity means an entity organized and operating within the United States that employs or engages with practitioners who prescribe controlled substances via a telehealth evaluation and, except in the case of an exempt entity, meets each of the following requirements:

(i) The telehealth entity does not, directly or indirectly, through a telehealth affiliate or otherwise, maintain an ownership interest, investment interest, or management relationship with any pharmacy that—

(I) does not dispense medications from physical locations that are accessible to the public; and

(II) fills and delivers the majority of its pharmaceutical products via the mail service.

(ii) The telehealth entity does not, directly or indirectly, through a telehealth entity or otherwise, charge patients pursuant to a financial arrangement where patients agree to make recurring payments at regular intervals in exchange for medications or patient care services provided by a health care provider employed or engaged with the telehealth entity (or a telehealth affiliate).

(iii) For the duration of any 12-month period, no more than 50 percent of all charges for patient care services provided by a health care provider employed or engaged with the telehealth entity (or a telehealth affiliate) are paid by patients directly on an out-of-pocket basis.

(iv) At least 25 percent of the total actual time spent performing patient care services by all health care providers engaged or employed by the telehealth entity (or a telehealth affiliate) relates to the diagnosis, treatment, prevention, or study of mental health disorders.

(v) At least 10 percent of all health care providers employed or engaged by the telehealth entity (or a telehealth affiliate), excluding any covering practitioners, are practitioners who are bona fide employees who work at least 30 hours per week for the telehealth entity.

(vi) At least 25 percent of all health care providers employed or engaged by the telehealth entity (or a telehealth affiliate), excluding any covering practitioners, are bona fide employees of the telehealth entity who work at least 30 hours per week for the entity.

(vii) The total number of advanced practice nurses employed or engaged with the telehealth entity (or a telehealth affiliate), excluding any covering practitioners, does not exceed two-thirds of the total number of practitioners employed or engaged with the telehealth entity (or a telehealth affiliate).

(viii) Neither the telehealth entity nor any telehealth affiliate compensates any practitioner in a manner where more than 75 percent of the total annual compensation of such practitioner varies, directly or indirectly, with the volume or value of telehealth evaluations provided by such practitioner.

(ix) The telehealth entity (or a telehealth affiliate) at all times employs a full-time Chief Compliance Officer who—

(I) dedicates the majority of such individual’s time working for the telehealth entity on compliance matters; and

(II) does not also serve as the Chief Clinical Quality Practitioner or Chief Medical Officer.

(x) The telehealth entity (or a telehealth affiliate) at all times employs a full-time Chief Clinical Quality Practitioner who—

(I) is a board-certified psychiatrist;

(II) dedicates the majority of such individual’s time working for the telehealth entity on clinical quality matters; and

(III) does not also serve as the Chief Compliance Officer or Chief Medical Officer for the telehealth entity.

(xi) The telehealth entity (or a telehealth affiliate) at all times employs a full-time Chief Medical Officer who—

(I) is a board-certified psychiatrist;

(II) dedicates the majority of such individual’s time working for the telehealth entity on clinical quality matters; and

(III) does not also serve as the Chief Compliance Officer or Chief Clinical Quality Practitioner of the telehealth entity.

(xii) The telehealth entity conducts routine monitoring to ensure all approved mental health controlled substances prescribed by telehealth practitioners employed or engaged by the telehealth entity are prescribed only for the conditions, and only in the manner of administration and oversight, approved by the Food and Drug Administration.

(xiii) The telehealth entity at all times maintains active accreditation from the Accreditation Counsel for Continuing Medical Education.

(Q) The term telehealth evaluation means a medical evaluation that is conducted in accordance with applicable Federal and State laws by a health care provider who is—

(i) at a location remote from the patient; and

(ii) communicating with the patient using an interactive telecommunications system.

(R) The term telehealth practitioner means a psychiatrist or a psychiatric-mental health advanced practice nurse who meets the following requirements:

(i) The individual is an employee or independent contractor of a telehealth entity.

(ii) Except in the case of an exempt entity, the individual works at least 10 hours per week for the telehealth entity.

(iii) Except in the case of an exempt entity, no more than 75 percent of the total annual compensation received by the individual from the telehealth entity (or a telehealth affiliate) varies with the volume or value of the telehealth evaluations provided by such practitioner.

(iv) The individual only prescribes controlled substances under subparagraph (A)(ii) for one telehealth entity in any given calendar month.

(d) Minimum standards before refusing To fill a prescription

Section 309(e) of such Act (21 U.S.C. 829(e)) is amended by adding at the end the following:

(A) Prohibition

A pharmacist shall not refuse to fill a prescription for a controlled substance issued in compliance with this subsection based solely upon a concern the prescription was issued via a telehealth evaluation.

(B) Validation of prescription

Before a pharmacist can refuse to fill a prescription based solely upon a concern with the validity of the prescription, the pharmacist shall attempt to resolve those concerns and shall attempt to validate the prescription by performing the following:

(i) Initiate communication with the patient (or the patient’s representative) to acquire information relevant to the concern with the validity of the prescription.

(ii) Initiate communication with the prescriber or the prescriber’s agent to—

(I) describe the pharmacist’s concern with the validity of the prescription; and

(II) acquire information relevant to the pharmacist’s concern with the validity of the prescription.

(C) Civil penalty

Any person who violates this paragraph shall, with respect to any such violation, be subject to a civil penalty of up to $25,000 per violation.

(1) Practice of telemedicine defined

Section 102(54)(E) of such Act (21 U.S.C. 802(54)(E)) is repealed.

(2) Special registration for telemedicine

Section 311(h) of such Act (21 U.S.C. 831(h)) is repealed.

(f) Effective date

The amendments made by this section shall take effect on the date of enactment of this Act.

(a) In general

Section 302(e) of such Act (21 U.S.C. 822(e)) is amended by adding at the end the following:

(A) Notwithstanding paragraph (1), a registrant shall not be required to obtain additional registrations with the Drug Enforcement Administration in any additional State where the dispensing (including prescribing and administering) occurs if the dispensing is conducted via the practice of telemedicine or following a telehealth evaluation.

(B) A registrant who is employed or contracted with a telehealth entity may use the address of such telehealth entity as the principal place of business or professional practice of the registrant so long as the registrant—

(i) is a telehealth practitioner; and

(ii) only dispenses (including prescribing and administering) controlled substances via the practice of telemedicine or a telehealth evaluation.

(b) Effective date

The amendment made by subsection (a) shall take effect on the date of enactment of this Act.

(a) In general

In the case of a covered psychiatrist who has in effect medical professional liability insurance coverage and provides in a secondary State covered psychiatry services that are within the scope of practice of such covered psychiatrist in the primary State to a patient—

(1) such medical professional liability insurance coverage shall cover (subject to any related premium adjustments) such covered psychiatrist with respect to such covered psychiatry services provided by the psychiatrist in the secondary State to such patient as if such services were provided by such psychiatrist in the primary State to such patient; and

(2) to the extent such covered psychiatrist is licensed under the requirements of the primary State to provide such services to such patient, the psychiatrist shall be treated as satisfying any licensure requirements of the secondary State to provide such services to such patient to the extent the licensure requirements of the secondary State are substantially similar to the licensure requirements of the primary State.

(b) Rule of construction

Nothing in this section shall be construed—

(1) to allow a covered psychiatrist to provide psychiatry services in the secondary State that exceed the scope of that psychiatrist’s license in the primary State; or

(2) to allow a covered psychiatrist to provide psychiatry services in the secondary State that exceed the scope of a substantially similar psychiatrist license in the secondary State.

(c) Definitions

In this Act:

(1) Covered psychiatrist

The term covered psychiatrist means a physician—

(A) who has completed a psychiatry residency program accredited by the Accreditation Council for Graduate Medical Education;

(B) whose practice focuses predominantly on the diagnosis, treatment, prevention, or study of mental health disorders; and

(C) who is licensed to practice in the primary State.

(2) Covered psychiatry services

The term covered psychiatry services means medical care relating to the diagnosis, treatment, or prevention of mental health or behavioral health disorders conducted by a covered psychiatrist who is at a location remote from the patient and is communicating with the patient through the use of telehealth technologies.

(3) License

The term license or licensure, as applied with respect to a covered psychiatrist, means a psychiatrist that has met the requirements and is approved to provide covered psychiatry services in accordance with State laws and regulations in the primary State.

(4) Primary state

The term primary State means, with respect to a covered psychiatrist, the State in which—

(A) the covered psychiatrist is licensed to practice; and

(B) the majority of the covered psychiatrist’s practice is underwritten for medical professional liability insurance coverage.

(5) Secondary state

The term secondary State means, with respect to a covered psychiatrist, any State that is not the primary State.

(6) State

The term State means each of the several States, the District of Columbia, and each commonwealth, territory, or possession of the United States.

(7) Substantially similar

The term substantially similar, with respect to the licensure by primary and secondary States of a psychiatrist, means that both the primary and secondary States have in place a form of licensure for such professionals that permits such professionals to provide covered psychiatry services.

(8) Telehealth technologies

The term telehealth technologies means technologies relating to the use of electronic information and telecommunication technologies, to support and promote, at a distance, health care, patient and professional health-related education, health administration, and public health.

(d) Effective date

This section shall take effect on the date of enactment of this Act.

Section 5. State laws affected

The provisions of this Act (including the amendments made by this Act) supersede and preempt any State statute, regulation, order, or interpretation to the extent such statute, regulation, order, or interpretation would directly or indirectly prohibit or restrict the activities permitted by this Act (or the amendments made by this Act).

to ask questions about this bill.